NO20015003D0 - Nucleic Acids Encoding CD40 / CD40L Chimeric Polypeptides, Methods of Preparation and Use thereof - Google Patents
Nucleic Acids Encoding CD40 / CD40L Chimeric Polypeptides, Methods of Preparation and Use thereofInfo
- Publication number
- NO20015003D0 NO20015003D0 NO20015003A NO20015003A NO20015003D0 NO 20015003 D0 NO20015003 D0 NO 20015003D0 NO 20015003 A NO20015003 A NO 20015003A NO 20015003 A NO20015003 A NO 20015003A NO 20015003 D0 NO20015003 D0 NO 20015003D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- methods
- nucleic acids
- acids encoding
- chimeric polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99107611A EP1067194A1 (en) | 1999-04-16 | 1999-04-16 | Vectors containing a gene coding for CD40 and/or CD40L under the control of a cytokine-inducible promoter which is a human acute phase amyloid A gene promoter. Methods for their production and uses thereof |
EP99113967 | 1999-07-17 | ||
PCT/EP2000/003318 WO2000063395A1 (en) | 1999-04-16 | 2000-04-13 | Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20015003L NO20015003L (en) | 2001-10-15 |
NO20015003D0 true NO20015003D0 (en) | 2001-10-15 |
Family
ID=26152970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20015003A NO20015003D0 (en) | 1999-04-16 | 2001-10-15 | Nucleic Acids Encoding CD40 / CD40L Chimeric Polypeptides, Methods of Preparation and Use thereof |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1173589A1 (en) |
JP (1) | JP2003508016A (en) |
AR (1) | AR023482A1 (en) |
AU (1) | AU3966200A (en) |
CA (1) | CA2369820A1 (en) |
IL (1) | IL144952A0 (en) |
NO (1) | NO20015003D0 (en) |
WO (1) | WO2000063395A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4271440B2 (en) | 2000-10-02 | 2009-06-03 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | Human anti-CD40 antibody |
AU2002221780A1 (en) * | 2000-10-31 | 2002-05-15 | F.Hoffmann-La Roche Ag | Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof |
EP2243491A1 (en) | 2003-11-04 | 2010-10-27 | Novartis Vaccines and Diagnostics, Inc. | Use of antagonist anti-CD40 monoclonal antibodies for treatment of chronic lymphocytic leukemia |
JP4810431B2 (en) | 2003-11-04 | 2011-11-09 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | Method for treating cancer associated with B cells |
ATE447412T1 (en) | 2003-11-04 | 2009-11-15 | Novartis Vaccines & Diagnostic | ANTAGONIST ANTI-CD40 MONOCLONAL ANTIBODIES AND METHODS OF USE |
PL1680141T3 (en) | 2003-11-04 | 2011-04-29 | Novartis Vaccines & Diagnostics Inc | Methods of therapy for solid tumors expressing the cd40 cell-surface antigen |
PL1684805T3 (en) | 2003-11-04 | 2010-12-31 | Novartis Vaccines & Diagnostics Inc | Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma |
DK1889065T3 (en) | 2005-05-18 | 2013-09-02 | Xoma Technology Ltd | METHODS OF DIAGNOSIS AND TREATMENT OF DISEASES WITH AN AUTO-IMMUNE AND / OR INFLAMMATION COMPONENT |
MEP39508A (en) | 2006-04-21 | 2011-02-10 | Novartis Ag | Antagonist anti-cd40 antibody pharmaceutical compositions |
PL2066339T3 (en) | 2006-09-18 | 2015-02-27 | Univ Arkansas | Compositions and methods of enhancing immune responses |
US9125854B2 (en) | 2007-10-30 | 2015-09-08 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses to flagellated bacterium |
DK3097926T3 (en) | 2007-11-01 | 2019-12-16 | Univ Arkansas | Compositions and Methods for Boosting Immune Reactions on Eimeria |
JP5568807B2 (en) * | 2008-06-06 | 2014-08-13 | 静岡県 | Identification of melanoma markers using proteomic analysis |
DK2525817T3 (en) | 2010-01-21 | 2017-10-02 | Univ Arkansas | Vaccine vectors and methods for enhancing immune responses |
NZ702839A (en) | 2010-06-09 | 2016-04-29 | Univ Arkansas | Vaccine and methods to reduce campylobacter infection |
WO2012075111A1 (en) | 2010-11-30 | 2012-06-07 | Novartis Ag | Uses of anti-cd40 antibodies in combination therapy for b cell-related cancers |
PT2956165T (en) | 2013-02-14 | 2019-11-29 | Texas A & M Univ Sys | Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection |
AU2014239557B2 (en) | 2013-03-15 | 2019-01-03 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses to enteric pathogens |
JP7467027B2 (en) | 2016-05-03 | 2024-04-15 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー | Yeast vaccine vectors containing immunostimulatory and antigenic polypeptides and methods of using same |
AU2017362730B2 (en) * | 2016-11-21 | 2021-04-08 | Nant Holdings Ip, Llc | Fractal combination therapy |
CA3098498A1 (en) * | 2018-06-14 | 2019-12-19 | Nantbio, Inc. | Tnf-type receptor-ligand fusion proteins and methods |
WO2020073045A1 (en) * | 2018-10-05 | 2020-04-09 | Nantcell, Inc. | Cd40 and cd40l combo in an adenovirus vaccine vehicle |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE239790T1 (en) * | 1991-10-25 | 2003-05-15 | Immunex Corp | ANTIBODIES AGAINST CD40-L |
US5716805A (en) * | 1991-10-25 | 1998-02-10 | Immunex Corporation | Methods of preparing soluble, oligomeric proteins |
US7070771B1 (en) * | 1996-12-09 | 2006-07-04 | Regents Of The University Of California | Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells |
-
2000
- 2000-04-13 EP EP00918873A patent/EP1173589A1/en not_active Withdrawn
- 2000-04-13 IL IL14495200A patent/IL144952A0/en unknown
- 2000-04-13 JP JP2000612474A patent/JP2003508016A/en active Pending
- 2000-04-13 WO PCT/EP2000/003318 patent/WO2000063395A1/en not_active Application Discontinuation
- 2000-04-13 CA CA002369820A patent/CA2369820A1/en not_active Abandoned
- 2000-04-13 AR ARP000101716A patent/AR023482A1/en unknown
- 2000-04-13 AU AU39662/00A patent/AU3966200A/en not_active Abandoned
-
2001
- 2001-10-15 NO NO20015003A patent/NO20015003D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1173589A1 (en) | 2002-01-23 |
CA2369820A1 (en) | 2000-10-26 |
AU3966200A (en) | 2000-11-02 |
IL144952A0 (en) | 2002-06-30 |
JP2003508016A (en) | 2003-03-04 |
WO2000063395A1 (en) | 2000-10-26 |
NO20015003L (en) | 2001-10-15 |
AR023482A1 (en) | 2002-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20015003L (en) | Nucleic Acids Encoding CD40 / CD40L Chimeric Polypeptides, Methods of Preparation and Use thereof | |
ZA200110161B (en) | Anti-avB3 recombinant human antibodies, nucleic acids encoding same and methods of use. | |
WO2003023008A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
NO20024774L (en) | [1,4`] -bipiperidine Compounds, Methods for Preparing and Using Them, Pharmaceutical Preparation, and Intermediates | |
AU2002221780A1 (en) | Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof | |
EP1576169A4 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU9633301A (en) | Paad domain-containing polypeptides, encoding nucleic acids, and methods of use | |
EP1487864A4 (en) | Therapeutic polypeptides nucleic acids encoding same, and methods of use | |
AU2002356534A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
EP1446419A4 (en) | Therapeutic polypeptides, nucleic acids encoding the same, and methods of use | |
EP1432726A4 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
EP1401858A4 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU2003217956A8 (en) | Therapeutic polypeptides, nucleic acids encoding same and methods of use | |
EP1695078A4 (en) | Metadherin polypeptides, encoding nucleic acids and methods of use | |
AU2003247537A8 (en) | Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof | |
EP1539985A4 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
EP1532238A4 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU2002365905A8 (en) | Transaminases, nucleic acids encoding them and methods of making and using them | |
EP1443913A4 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
EP1399537A4 (en) | Therapeutic polypeptides, nucleic acids encoding same and methods of use | |
EP1549671A4 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU2002365216A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU2003304034A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2003060149A9 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU2003270424A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |